RadMD Appoints Pharma Veteran Douglas Stefanelli to New Position of Chief Operating Officer and Executive Vice President

DOYLESTOWN, PA--(Marketwire - April 12, 2011) - RadMD, LLC (www.rad-md.net) today announced that Douglas Stefanelli has joined the RadMD Senior Management team as COO and Executive VP. Mr. Stefanelli will take over responsibility for the company’s day-to-day operating activities, and will direct the short-term and long-range planning and development to support the company’s strategic business goals. He brings with him more than twenty-seven years of experience in the pharmaceutical industry managing businesses in both therapeutic and diagnostic areas.

“Doug joins RadMD as an experienced, senior level Healthcare Executive with a track record of success. Specializing in creating new markets, developing large brands and overall business development,” said Rick Patt, M.D., one of RadMD’s Principals, “Doug will help us further build our organization and lead our commercial operations in the United States and abroad.”

Prior to joining RadMD, Mr. Stefanelli held the position of Vice President and General Manager for Bayer Healthcare where he was responsible for managing the Diagnostic Imaging business in the US. He began his career in Sales for Berlex Laboratories and later moved through increasing responsibilities in Marketing, holding positions as Director and Vice President of Marketing for both Specialized Therapeutics and Diagnostic Imaging. He has significant experience in both medical imaging and neurology therapeutics. In addition to his Marketing experience Mr. Stefanelli also managed the Business Analytics Department at Berlex as Vice President and Executive Committee member. He received his BS in Chemistry from St. John’s University.

About RadMD

RadMD, LLC (www.rad-md.net) provides a suite of expertise-based services around the use of imaging in clinical trials: defining imaging strategies in clinical development programs; providing CME-certified education and training; sourcing and management of over 600 independent physician reviewers; managing imaging vendor selection and oversight.